Loading...

DXCM DEXCOM INC Management Changes 8-K Filing

DXCM

DXCM

DEXCOM INC

(DXCM)

2025 8-K

Summary

Summary

Leadership Change

Equity Offerings

Board Appointment

FDA Warning Letter

Financial Results

Financial Results

Patent Settlement

Financial Results

Financial Results and Share...

Annual Meeting of Stockholders

Financial Results Announcement

Termination of Warrants

Financial Results Announcement

Preliminary Financial Results

Share Repurchase Agreement

Financial Results Announcement

Share Repurchase Program

Earnings Reports

Regulation FD Disclosure

Severance Plan Amendments

Sale of Convertible Senior ...

Earnings Reports

Financial Results Announcement

Financial Results

External Links:

On July 25, 2025, Dexcom announced the retirement of CEO Kevin R. Sayer effective January 1, 2026, and appointed Jacob S. Leach as the new CEO. Additionally, the Board will expand to ten directors starting January 1, 2026.

AI Assistant

DEXCOM INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.